Atenolol in the prophylaxis of chronic migraine: a 3-month open-label study
| العنوان: | Atenolol in the prophylaxis of chronic migraine: a 3-month open-label study |
|---|---|
| المؤلفون: | Bengt Edvardsson |
| المصدر: | SpringerPlus; 2(Sep 22), no 479 (2013) SpringerPlus |
| بيانات النشر: | Springer, 2013. |
| سنة النشر: | 2013 |
| مصطلحات موضوعية: | medicine.medical_specialty, Multidisciplinary, Neurology, Beta blockers, business.industry, Research, Significant difference, Headache, Primary care, medicine.disease, Atenolol, Chronic daily headache, Surgery, Chronic Migraine, Open label study, Migraine, Tolerability, Internal medicine, Medicine, business, medicine.drug, Chronic migraine |
| الوصف: | Background Chronic migraine (CM) is a type of chronic daily headache. CM presents a challenge to primary care physicians and neurologists. Any new treatment showing efficiency would therefore be of great importance. Atenolol together with other beta-blockers is a first-line choice in episodic migraine prophylaxis. Clinical findings support the efficacy of atenolol in doses of 50 to 200 mg/day. Methods Here I present an open-label study the aim of which is to evaluate the efficacy and tolerability of atenolol (50 mg o.d) for the prevention of CM. 19 patients affected by CM were studied. Results Following a one-month run-in period, the patients took atenolol for 3 months. Mean numbers of headache days per month were reduced from 20.1 ± 2.4 during the run-in period to 7.8 ± 6.1 by month 1.5 and to 7.1 ± 5.7 by the 3rd month of treatment (p |
| وصف الملف: | application/pdf |
| اللغة: | English |
| تدمد: | 2193-1801 |
| الوصول الحر: | https://explore.openaire.eu/search/publication?articleId=doi_dedup___::567b1931e376f7c36b950431974cda31Test https://lup.lub.lu.se/record/4143778Test |
| حقوق: | OPEN |
| رقم الانضمام: | edsair.doi.dedup.....567b1931e376f7c36b950431974cda31 |
| قاعدة البيانات: | OpenAIRE |
| تدمد: | 21931801 |
|---|